Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
publishDate:"[2020 TO 2029]"
publishDate:"[2022 TO 2022]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=publishDate%3A%22%5B2022+TO+2022%5D%22&lookfor=%22Hanley%2C+Michael+J%22&type=Person
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=publishDate%3A%22%5B2022+TO+2022%5D%22&lookfor=%22Hanley%2C+Michael+J%22&type=Person
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=publishDate%3A%22%5B2022+TO+2022%5D%22&lookfor=%22Hanley%2C+Michael+J%22&type=Person
PubPharm (12)
1
Population pharmacokinetic/pharmacodynamic joint modeling of ixazomib efficacy and safety using data from the pivotal phase III TOURMALINE-MM1 study in multiple myeloma patients
enthalten in:
CPT: pharmacometrics & systems pharmacology
| 2022
von
Srimani, J.
|
Diderichsen, P.
|
Hanley, M.
| +3
Wird geladen...
2
Mobocertinib Dose Rationale in Patients with Metastatic NSCLC with EGFR Exon 20 Insertions : Exposure-Response Analyses of a Pivotal Phase I/II Study
enthalten in:
Clinical pharmacology and therapeutics
| 2022
von
Gupta, N.
|
Largajolli, A.
|
Witjes, H.
| +5
Wird geladen...
3
Pharmacometric analyses and clinical evidence for brigatinib dosing in anaplastic lymphoma kinase-positive non-small cell lung cancer
enthalten in:
British journal of clinical pharmacology
| 2022
von
Gupta, N.
|
Hanley, M.
|
Sinha, V.
CommentOn: Br J Clin Pharmacol. 2022 Feb;88(4):1930-1934. - PMID 34545619
Wird geladen...
4
Population pharmacokinetics of mobocertinib in healthy volunteers and patients with non-small cell lung cancer
enthalten in:
CPT: pharmacometrics & systems pharmacology
| 2022
von
Gupta, N.
|
Pierrillas, P.
|
Hanley, M.
| +2
Wird geladen...
5
Population pharmacokinetic and exposure-response analyses from ALTA-1L : Model-based analyses supporting the brigatinib dose in ALK-positive NSCLC
enthalten in:
Clinical and translational science
| 2022
von
Gupta, N.
|
Reckamp, K.
|
Camidge, D.
| +8
Wird geladen...
6
Population Pharmacokinetics of Ponatinib in Healthy Adult Volunteers and Patients With Hematologic Malignancies and Model-Informed Dose Selection for Pediatric Development
enthalten in:
Journal of clinical pharmacology
| 2022
von
Hanley, M.
|
Diderichsen, P.
|
Narasimhan, N.
| +3
Wird geladen...
7
Pharmacometric analyses and clinical evidence for brigatinib dosing in anaplastic lymphoma kinase‐positive non‐small cell lung cancer
enthalten in:
British Journal of Clinical Pharmacology
| 2022
von
Gupta, N.
|
Hanley, M.
|
Sinha, V.
Wird geladen...
8
Mobocertinib Dose Rationale in Patients with Metastatic NSCLC with EGFR Exon 20 Insertions : Exposure–Response Analyses of a Pivotal Phase I/II Study
enthalten in:
Clinical Pharmacology & Therapeutics
| 2022
von
Gupta, N.
|
Largajolli, A.
|
Witjes, H.
| +5
Wird geladen...
9
Population pharmacokinetic and exposure‐response analyses from ALTA‐1L : Model‐based analyses supporting the brigatinib dose in ALK‐positive NSCLC
enthalten in:
Clinical and Translational Science
| 2022
von
Gupta, N.
|
Reckamp, K.
|
Camidge, D.
| +8
Wird geladen...
10
Population Pharmacokinetics of Ponatinib in Healthy Adult Volunteers and Patients With Hematologic Malignancies and Model‐Informed Dose Selection for Pediatric Development
enthalten in:
The Journal of Clinical Pharmacology
| 2022
von
Hanley, M.
|
Diderichsen, P.
|
Narasimhan, N.
| +3
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2020-2029
Filter aufheben
Erscheinungsjahr: 2022-2022
Medienart
12
Aufsätze
12
E-Artikel
12
E-Ressourcen
Zeitschriftentitel
2
CPT: Pharmacometrics & Systems Pharmacology
2
CPT: pharmacometrics & systems pharmacology
1
British Journal of Clinical Pharmacology
1
British journal of clinical pharmacology
1
Clinical Pharmacology & Therapeutics
1
Clinical and Translational Science
1
Clinical and translational science
1
Clinical pharmacology and therapeutics
1
Journal of clinical pharmacology
1
The Journal of Clinical Pharmacology
Alle anzeigen ...
weniger ...
Thema
6
Research Support, Non-U.S. Gov't
5
Journal Article
5
Protein Kinase Inhibitors
3
EC 2.7.10.1
2
Anaplastic Lymphoma Kinase
2
Clinical Trial, Phase I
2
Clinical Trial, Phase II
2
HYW8DB273J
2
Organophosphorus Compounds
2
Pyrimidines
2
brigatinib
1
4340891KFS
1
71050168A2
1
Antineoplastic Agents
1
BCR-ABL
1
Boron Compounds
1
Comment
1
EC 2.7.10.2
1
EGFR protein, human
1
ErbB Receptors
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2022-2022
Erscheinungsjahr(e)
Von:
Bis:
Sprache
6
Englisch
Haven't found what you're looking for?
Wird geladen...